Patents by Inventor Fernando Martínez-Alzamora

Fernando Martínez-Alzamora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL TRAMADOL COMPOSITION FOR OPHTHALMIC USE
    Publication number: 20190224114
    Abstract: The present invention relates to a pharmaceutical tramadol composition for ophthalmic use. The composition is characterised in that it contains tramadol in a low concentration, specifically between 0.02% and 0.09%, and in that it is highly efficient in the treatment of ocular pain, for example following injuries or ocular surgery, or the ocular pain associated with dry eye syndrome.
    Type: Application
    Filed: September 5, 2016
    Publication date: July 25, 2019
    Inventors: Nuria Sanz Menendez, Raquel Horcajada Cordoba, Fernando Martinez-Alzamora, Rocío Herrero Vanrell, José Manuel Benitez Del Castillo
  • Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use
    Patent number: 10292953
    Abstract: The present invention relates to a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. Said composition is effective and safe for the treatment of ocular inflammation and/or pain associated to different diseases or pathological states which affect the eye area In particular, the ophthalmic composition of the invention is indicated, for example, for the treatment of pain and/or inflammation after eye surgery.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: May 21, 2019
    Inventors: Fernando Martinez-Alzamora, Jose Miguel Rizo Martinez, Antonia Gomez Calvo, Nuria Sanz Menendez, Angel Munoz Ruiz
  • Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use
    Patent number: 10016428
    Abstract: The present invention refers to a pharmaceutical composition of sildenafil citrate in the form of a suspension for administration orally that comprises water as a vehicle and xanthan gum and hypromellose as suspension agents, that is highly stable and allows the efficient masking of the active ingredient's bitter taste. It also refers to a procedure for the preparation of said suspension and to a container that contains it and that is provided with a dosing device for its administration. This composition of sildenafil citrate in the form of a suspension is suitable for administration orally for the treatment of masculine sexual dysfunction.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: July 10, 2018
    Inventors: Fernando Martínez-Alzamora, Antonia Gómez Calvo, Miguel Rizo Martínez, Nuria Sanz Menéndez
  • PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRATE IN THE FORM OF A SUSPENSION FOR ORAL USE
    Publication number: 20160279133
    Abstract: The present invention refers to a pharmaceutical composition of sildenafil citrate in the form of a suspension for administration orally that comprises water as a vehicle and xanthan gum and hypromellose as suspension agents, that is highly stable and allows the efficient masking of the active ingredient's bitter taste. It also refers to a procedure for the preparation of said suspension and to a container that contains it and that is provided with a dosing device for its administration. This composition of sildenafil citrate in the form of a suspension is suitable for administration orally for the treatment of masculine sexual dysfunction.
    Type: Application
    Filed: March 22, 2016
    Publication date: September 29, 2016
    Inventors: Fernando Martínez-Alzamora, Antonia Gómez Calvo, Miguel Rizo Martínez, Nuria Sanz Menéndez
  • Pharmaceutical Composition of Ibuprofen and Tramadol for Ophthalmic Use
    Publication number: 20150105468
    Abstract: The present invention relates to a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. Said composition is effective and safe for the treatment of ocular inflammation and/or pain associated to different diseases or pathological states which affect the eye area In particular, the ophthalmic composition of the invention is indicated, for example, for the treatment of pain and/or inflammation after eye surgery.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 16, 2015
    Inventors: Fernando Martinez-Alzamora, Jose Miguel Rizo Martinez, Antonia Gomez Calvo, Nuria Sanz Menendez, Angel Munoz Ruiz